biote Corp. (BTMD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 30.10M USD | Liabilities, Current |
| Cash and equivalents | 11.17M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 7.81M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 18.33M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $30.10M | $11.17M | (m) | $7.81M | $18.33M | (m) |
| 2026-03-31 | (m) | $28.23M | $5.32M | (m) | $7.40M | $19.88M | (m) |
| 2025-12-31 | (m) | $44.99M | $24.12M | (m) | $6.87M | $19.06M | (m) |
| 2025-09-30 | (m) | $56.31M | $28.05M | (m) | $7.97M | $16.45M | (m) |
| 2025-06-30 | (m) | $50.54M | $19.60M | (m) | $9.07M | $12.13M | (m) |
| 2025-03-31 | (m) | $48.47M | $41.70M | (m) | $7.76M | $13.45M | (m) |
| 2024-12-31 | (m) | $51.51M | $39.34M | (m) | $7.63M | $14.85M | (m) |
| 2024-09-30 | (m) | $46.51M | $38.23M | (m) | $8.49M | $16.20M | (m) |
| 2024-06-30 | (m) | $46.27M | $26.42M | (m) | $7.70M | $19.21M | (m) |
| 2024-03-31 | (m) | $24.06M | $78.79M | (m) | $8.02M | $18.92M | (m) |
| 2023-12-31 | (m) | $22.21M | $89.00M | (m) | $6.81M | $17.31M | (m) |
| 2023-09-30 | (m) | $25.08M | $65.58M | (m) | $10.18M | $11.08M | (m) |
| 2023-06-30 | (m) | $21.73M | $68.48M | (m) | $8.34M | $7.40M | (m) |
| 2023-03-31 | (m) | $19.86M | (m) | (m) | $7.65M | $9.62M | (m) |
| 2022-12-31 | (m) | $18.77M | (m) | (m) | $6.95M | $11.18M | (m) |
| 2022-09-30 | (m) | $22.39M | (m) | (m) | $7.63M | $10.18M | (m) |
| 2022-06-30 | (m) | $32.94M | (m) | (m) | $6.82M | $9.81M | (m) |
| 2022-03-31 | (m) | $3.23M | $67.90K | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $2.27M | $130.36K | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $79.94K | $294.92K | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $49.31K | $484.09K | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $58.53K | $922.48K | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $122.50K | $1.59K | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $250.00 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.